RGCRegencell Bioscience Holdings Limited
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -94% · now 86% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can RGC take a bad year?
The deepest fall in RGC's price history on file is −94%; it is 86% below its high today.
Worst drawdown on file · −86% today
- Cash runway
- 1.5 years
Cash runway · burning $817K a quarter at the current rate
- Annualised volatility
- 337%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $4.9M
- EBITDA, trailing twelve months
- −$3.7M
- Operating profit, trailing twelve months
- −$3.8M
- Annualised volatilitytwo years of daily moves
- 337%
- Worst drawdown on file
- −94%
- Below its 52-week high
- 86%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers, Specialty & Generic
Ranks #40 of 41 by RyuScore